学术探索
学术期刊
新闻热点
数据分析
智能评审

Pharmacokinetic considerations in obesity

被引：137
作者：
Blouin, RA [1 ]
Warren, GW
机构：
[1] Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA
[2] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA
来源：
JOURNAL OF PHARMACEUTICAL SCIENCES | 1999年 / 88卷 / 01期
关键词：
D O I：
10.1021/js980173a
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1 / 7
页数：7
相关论文
共 94 条
  • [21] SERUM-PROTEIN BINDING AND THE ROLE OF INCREASED ALPHA-1-ACID GLYCOPROTEIN IN MODERATELY OBESE MALE-SUBJECTS
    BENEDEK, IH
    BLOUIN, RA
    MCNAMARA, PJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (06) : 941 - 946
  • [22] BLOUIN RA, 1987, CLIN PHARMACY, V6, P706
  • [23] TOBRAMYCIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS
    BLOUIN, RA
    MANN, HJ
    GRIFFEN, WO
    BAUER, LA
    RECORD, KE
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) : 508 - 512
  • [24] VANCOMYCIN PHARMACOKINETICS IN NORMAL AND MORBIDLY OBESE SUBJECTS
    BLOUIN, RA
    BAUER, LA
    MILLER, DD
    RECORD, KE
    GRIFFEN, WO
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) : 575 - 580
  • [25] BLOUM RA, 1992, APPL PHARMACOKINETIC
  • [26] A COMPARISON OF THE PHARMACOKINETICS OF PROPRANOLOL IN OBESE AND NORMAL VOLUNTEERS
    BOWMAN, SL
    HUDSON, SA
    SIMPSON, G
    MUNRO, JF
    CLEMENTS, JA
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (05) : 529 - 532
  • [27] The OB protein (leptin) pathway - A link between adipose tissue mass and central neural networks
    Campfield, LA
    Smith, FJ
    Burn, P
    [J]. HORMONE AND METABOLIC RESEARCH, 1996, 28 (12) : 619 - 632
  • [28] CARBAMAZEPINE PHARMACOKINETICS IN OBESE AND LEAN SUBJECTS
    CARACO, Y
    ZYLBERKATZ, E
    BERRY, EM
    LEVY, M
    [J]. ANNALS OF PHARMACOTHERAPY, 1995, 29 (09) : 843 - 847
  • [29] CARACO Y, 1995, EUR J CLIN PHARMACOL, V47, P525
  • [30] SIGNIFICANT WEIGHT-REDUCTION IN OBESE SUBJECTS ENHANCES CARBAMAZEPINE ELIMINATION
    CARACO, Y
    ZYLBERKATZ, E
    BERRY, EM
    LEVY, M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (05) : 501 - 506
12345678910